The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type I particles

被引:70
作者
Herrera, C
Klasse, PJ
Michael, E
Kake, S
Bames, K
Kibler, CW
Campbell-Gardener, L
Si, ZH
Sodroski, J
Moore, JP
Beddows, S
机构
[1] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol,Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Canc Biol, Boston, MA 02115 USA
关键词
gp160; Env; HIV-1; cleavage; antigenicity; neutralizing antibodies; mutants;
D O I
10.1016/j.virol.2005.05.002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Endoproteolytic processing of the human immunodeficiency virus type 1 (HIV-1) envelope (Env) glycoproteins is an obligate part of the biosynthetic pathway that generates functional, fusion-competent Env complexes, which are then incorporated into infectious virions. We have examined the influence of cleavage on Env-specific antibody reactivity, Env incorporation into pseudovirions, and the infectivity and neutralization sensitivity of Env-pseudotyped viruses. To do so, we have used both incompletely processed wild-type (Wt) Env and engineered, cleavage-defective Env mutants. We find that there is no simple association between antibody reactivity to cell surface-expressed Env, and the ability of the same antibody to neutralize virus pseudotyped with the same Env proteins. One explanation for the absence of such an association is the diverse array of Env species present on the surface of transiently transfected cells. We also confirm that cleavage-defective mutants are antigenically different from Wt Env. These findings have implications for the use of Env binding assays as predictors of neutralizing activity, and for the development of cleavage-defective Env trimers for use as subunit immunogens. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:154 / 172
页数:19
相关论文
共 88 条
[1]   The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle [J].
Abrahamyan, LG ;
Mkrtchyan, SR ;
Binley, J ;
Lu, M ;
Melikyan, GB ;
Cohen, FS .
JOURNAL OF VIROLOGY, 2005, 79 (01) :106-115
[2]   Stepwise deletion of the HIV type I glycoprotein 41 N terminus leads to an increasing export of microvesicles containing uncleaved env glycoprotein [J].
Adams, O ;
Scheid, A .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (14) :1345-1356
[3]  
BARNDORFFNIELSE.OE, 2001, QUANTITATIVE FINANCE, V1, P1
[4]   Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[5]   Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins [J].
Berlioz-Torrent, C ;
Shacklett, BL ;
Erdtmann, L ;
Delamarre, L ;
Bouchaert, I ;
Sonigo, P ;
Dokhelar, MC ;
Benarous, R .
JOURNAL OF VIROLOGY, 1999, 73 (02) :1350-1361
[6]   Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations [J].
Bess, JW ;
Gorelick, RJ ;
Bosche, WJ ;
Henderson, LE ;
Arthur, LO .
VIROLOGY, 1997, 230 (01) :134-144
[7]   Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].
Binley, JA ;
Wrin, T ;
Korber, B ;
Zwick, MB ;
Wang, M ;
Chappey, C ;
Stiegler, G ;
Kunert, R ;
Zolla-Pazner, S ;
Katinger, H ;
Petropoulos, CJ ;
Burton, DR .
JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252
[8]   Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1 [J].
Binley, JM ;
Klasse, PJ ;
Cao, YZ ;
Jones, I ;
Markowitz, M ;
Ho, DD ;
Moore, JP .
JOURNAL OF VIROLOGY, 1997, 71 (04) :2799-2809
[9]   Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins [J].
Binley, JM ;
Sanders, RW ;
Master, A ;
Cayanan, CS ;
Wiley, CL ;
Schiffner, L ;
Travis, B ;
Kuhmann, S ;
Burton, DR ;
Hu, SL ;
Olson, WC ;
Moore, JP .
JOURNAL OF VIROLOGY, 2002, 76 (06) :2606-2616
[10]   A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure [J].
Binley, JM ;
Sanders, RW ;
Clas, B ;
Schuelke, N ;
Master, A ;
Guo, Y ;
Kajumo, F ;
Anselma, DJ ;
Maddon, PJ ;
Olson, WC ;
Moore, JP .
JOURNAL OF VIROLOGY, 2000, 74 (02) :627-643